Pathophysiology and treatment of hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS) - European Medical Journal

Pathophysiology and treatment of hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)

Rheumatology

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Juan Ignacio Aróstegui Gorospe, MD, PhD, from the Hospital Clínic de Barcelona, Barcelona, Spain, talks about the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS).

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given